Publié le
Abstract: Purpose Pathologic complete response (pCR) has prognostic importance and is frequently used as a primary end point, but doubts…
Publié le
Strategic partnership to pair long-standing clinical research expertise with a best-in-class RTSM system
Publié le
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…
Publié le
Discover how a Sponsor reached the overall balance amongst 2 arms by adding a stratification factor.
Publié le
Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model. PLEASE FILL IN…
Publié le
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
Publié le
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
Publié le
PRESS RELEASE Clario to deliver industry leading Randomization, Trial Supply and Management SaaS for new partnership with IDDI Use of…
Publié le
Phase I/II study in cancer patients showcases eClinical effectiveness. An Article written by IDDI Published in Applied Clinical Trials, February…
Publié le
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
